Association for Molecular Pathology Inc

Nonprofit profile at a glance

EIN
311671642
IRS 990 coverage
2014–2024
Forms available
Form 990 2024, Form 990-T 2024
Location
Rockville, MD, USA
Phone
3016347987
Rating
79
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Education N.E.C.

Official website

Reported finances

Revenue
$6,277,389
Expenses
$7,491,195
Assets
$15,519,539
Liabilities
$3,038,225

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

36 people listed

Executive titles in this filing

  • MARIA E ARCILA MD (PRESIDENT (1/1-11/23/24))
  • JANE S GIBSON MS PHD (PRESIDENT (START 11/24/24))
  • MARY STEELE WILLIAMS MNA MT ASCPSM (EXECUTIVE DIRECTOR (THRU 1/2/24))
  • LAUREN S MENSER (CHIEF EXECUTIVE OFFICER-START 1/3/24)

Highest reported compensation

  • LAUREN S MENSER (CHIEF EXECUTIVE OFFICER-START 1/3/24): $385,837 total reported compensation
  • ROBYN TEMPLE-SMOLKIN (DIR CLINICAL/SCIENTIFIC AF): $204,303 total reported compensation
  • SARA HAMILTON (DIRECTOR OF MEETINGS & EXH): $181,264 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Advances the clinical practice, science, and excellence of molecular and genomic laboratory medicine through education, innovation, and advocacy to enable highest quality health care.

What it reported doing in 2024

Innovation and improved patient care (iipc) - see schedule o for complete descriptioniipc works to foster innovation to improve patient care and patient outcomes through programs that include issuing manuscripts, clinical practice guidelines, reports, and oversight of jmd's strategic direction.the journal of molecular diagnosticsthis is the official journal of amp. Monthly publication began in january 2020. These issues have original, high-quality manuscripts on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine.every published manuscript is scientifically peer reviewed.jmd is jointly owned with the american society for investigative pathology (asip) 94-6079945. Starting in 2011, elsevier began publishing jmd.

Operating model

Revenue model
Earned-program. 77% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 99% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. The filing reports few safeguards for money sent abroad and expenses are high relative to revenue.

Rating breakdown

  • Financial Efficiency: 75
  • Transparency & Controls: 75
  • Accountability: 100
  • Sustainability: 29
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 89.7%; rating input score 90
  • Program expense ratio: 74.6%; rating input score 75
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 4 of 6 controls in place; rating input score 67
    • Compensation committee: Pass
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Pass
    • Compensation survey or study: Pass
    • Board or committee approval: Pass
  • Foreign activity oversight: 1 of 8 controls in place; rating input score 12
    • Claims monitoring procedures: Pass
    • Requires narrative reports: Fail
    • Conducts field audits: Fail
    • May suspend future funding: Fail
    • Requires financial reports: Fail
    • Conducts site visits: Fail
    • Requires grant agreements: Fail
    • May require repayment: Fail
  • Grant itemization coverage: 100%; rating input score 100; 72nd percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 8 of 8 controls in place; rating input score 100
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Pass
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: -19.3%; rating input score 7; 7th percentile among comparable filings
  • Total-asset coverage ratio: 2.07; rating input score 63; 63rd percentile among comparable filings
  • Liabilities to assets ratio: 0.2; rating input score 44; 44th percentile among comparable filings
  • Officer compensation ratio: 17.9%; rating input score 15; 15th percentile among comparable filings

Growth

  • Program expense growth: 10.3% per year; rating input score 100; 65th percentile among comparable filings
  • Revenue growth: 4% per year; rating input score 100; 34th percentile among comparable filings
  • Asset growth: 7.4% per year; rating input score 100; 47th percentile among comparable filings

Details

  • Where the money goes: 89.7% of revenue deployed · 74.6% of spending went to programs
  • Governance: 19 of 19 board members independent · 8 of 8 filing controls reported
  • Programs: 4 filed program accomplishments · $5.6M in reported program spending
  • Leadership: top reported pay $386K · 36 people listed · 4 of 6 pay-setting controls reported
  • Highest-paid contractors: 4 contractors listed · $2.2M reported
  • Consistency: 39 of 39 current checks pass
  • Schedules: 8 filed schedules · includes major donors, foreign activity, grants, and executive pay
  • Filing history: 11 filing years from 2014 to 2024
  • Contacts: How to reach this organization
  • Money network: 7 filed money-flow records
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Transparency & Controls: Foreign activity oversight: 7 of 8 not reported.
  • High — Sustainability: Operating margin scored 7/100.
  • High — Sustainability: Officer compensation ratio scored 15/100.
  • Moderate — Sustainability: Liabilities to assets ratio scored 44/100.